← Back to headlines
BioNTech SE Rallies on Strong Oncology Strategy
BioNTech SE (BNTX) is experiencing a rally in its stock due to a solid oncology strategy.
19 Feb, 08:43 — 19 Feb, 08:43
Sources
Showing 1 of 1 sources
Related Stories
Second Victim Dies Following Catastrophic Fire in Omišu, Croatia
13m ago
UK Mayor Andy Burnham to Abstain on Assisted Dying Bill Vote
38m ago
BioNTech Shares Drop After Halting Mid-Stage Colorectal Cancer Vaccine Trial
1h ago
Dolly Parton Sought Experimental Cancer Treatments Before Death, Sister Reveals
1h ago